These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 37878227)

  • 1. Eicosanoids Signals in SARS-CoV-2 Infection: A Foe or Friend.
    Rahman MS; Hossain MS
    Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37878227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
    Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
    Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specialized pro-resolving lipid mediators regulate inflammatory macrophages: A paradigm shift from antibiotics to immunotherapy for mitigating COVID-19 pandemic.
    Kumar V; Yasmeen N; Chaudhary AA; Alawam AS; Al-Zharani M; Suliman Basher N; Harikrishnan S; Goud MD; Pandey A; Lakhawat SS; Sharma PK
    Front Mol Biosci; 2023; 10():1104577. PubMed ID: 36825200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19.
    Zaid Y; Doré É; Dubuc I; Archambault AS; Flamand O; Laviolette M; Flamand N; Boilard É; Flamand L
    J Allergy Clin Immunol; 2021 Aug; 148(2):368-380.e3. PubMed ID: 34111453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The need for precision nutrition, genetic variation and resolution in Covid-19 patients.
    Simopoulos AP; Serhan CN; Bazinet RP
    Mol Aspects Med; 2021 Feb; 77():100943. PubMed ID: 33551236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eicosanoids: The Overlooked Storm in Coronavirus Disease 2019 (COVID-19)?
    Hammock BD; Wang W; Gilligan MM; Panigrahy D
    Am J Pathol; 2020 Sep; 190(9):1782-1788. PubMed ID: 32650004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing SARS-CoV2 Infections Through Resolution of Inflammation by Eicosanoids: A Review.
    Mohammed A; Kalle AM; Reddanna P
    J Inflamm Res; 2022; 15():4349-4358. PubMed ID: 35937919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and cancer: start the resolution!
    Barksdale C; Kipper FC; Tripathy S; Subbian S; Serhan CN; Panigrahy D
    Cancer Metastasis Rev; 2022 Mar; 41(1):1-15. PubMed ID: 35190921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.
    Ahmed F
    Front Immunol; 2020; 11():590459. PubMed ID: 33362771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice.
    Dubuc I; Prunier J; Lacasse É; Gravel A; Puhm F; Allaeys I; Archambault AS; Gudimard L; Villano R; Droit A; Flamand N; Boilard É; Flamand L
    Front Immunol; 2022; 13():893792. PubMed ID: 35812400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine Storm and Failed Resolution in COVID-19: Taking a Cue from Multiple Sclerosis.
    Zahoor I; Li Y; Rattan R; Giri S
    Adv Exp Med Biol; 2021; 1352():211-222. PubMed ID: 35132603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed storm in SARS-CoV-2 infection: A narrative review and new term in the Covid-19 era.
    Alomair BM; Al-Kuraishy HM; Al-Gareeb AI; Al-Buhadily AK; Alexiou A; Papadakis M; Alshammari MA; Saad HM; Batiha GE
    Immun Inflamm Dis; 2023 Apr; 11(4):e838. PubMed ID: 37102645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broadening COVID-19 Interventions to Drug Innovation: Neprilysin Pathway as a Friend, Foe, or Promising Molecular Target?
    Rex DAB; Arun Kumar ST; Modi PK; Keshava Prasad TS
    OMICS; 2021 Jul; 25(7):408-416. PubMed ID: 34191617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavonoids against the SARS-CoV-2 induced inflammatory storm.
    Liskova A; Samec M; Koklesova L; Samuel SM; Zhai K; Al-Ishaq RK; Abotaleb M; Nosal V; Kajo K; Ashrafizadeh M; Zarrabi A; Brockmueller A; Shakibaei M; Sabaka P; Mozos I; Ullrich D; Prosecky R; La Rocca G; Caprnda M; Büsselberg D; Rodrigo L; Kruzliak P; Kubatka P
    Biomed Pharmacother; 2021 Jun; 138():111430. PubMed ID: 33662680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications.
    Ong WY; Go ML; Wang DY; Cheah IK; Halliwell B
    Mol Neurobiol; 2021 Jan; 58(1):106-117. PubMed ID: 32897518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.